The modulation of immune system activity is a required pharmacological intervention for many medical conditions, bearing particular importance in the treatment of autoimmune diseases and allergies and transplant procedures. With traditional immunomodulatory drugs continuing to exhibit limited efficacy and adverse side effects, the drive to develop new, improved, and specifically targeted immunotherapies has been gaining momentum. ’Immunomodulators: Therapeutic Needs, Pipelines & Prospects’ is a new report published by Business Insights that provides a detailed examination of the current market for immunomodulatory therapies. The strategies and technologies used in immunomodulation are analysed and the major clinical applications of immunomodulators are reviewed to identify the leading drug classes and most promising agents currently in development. This report will also investigate patient metrics and provide market forecasts for immunomodulators to 2011.
